After a volatile start to the year, the stock market appears to be regaining its footing. While the first four months were ...

List today: Cronos Group Inc. CRON: This cannabinoid company has seen the Zacks Consensus Estimate for its current year ...

Ed Yardeni, Yardeni Research president, appeared on CNBC’s ‘Closing Bell’ to talk about market outlook and more.

These five top Buy-rated dividend stocks were among S&P 500's top performers so far this year and still offer strong total ...

Discover why Blackstone earns a strong buy rating with unmatched capital, record dry powder, and growth in private wealth.

In fact, the firm boasts 13 "strong buy" or equivalent ratings, and 47 more "buy" ratings on top of that. CEO Mark Zuckerberg's public presence at the inauguration of President Donald Trump, ...

There’s no guarantee that even the “strong buy” stocks that are identified by market pros are going to go up, and there are plenty of cases where the analyst community was dead wrong.

We used Finviz and Tipranks to make a list of 35 strong buy stocks. We then selected the top 10 stocks with the highest analyst upside potential as of March 12, 2025.

DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Carlsberg (CABGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Four Dividend Aristocrat stocks that most investors are familiar with are among the longevity champions and pay among the highest dividends.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Cronos Group Inc. CRON: This cannabinoid company has seen the Zacks Consensus Estimate for its current year earnings ...